Autonomic snags $20M to treat headaches
Autonomic Technologies, maker of implantable devices that can soothe severe headaches, has raised $20 million in a second round of funding led by InterWest Partners. The Menlo Park, Calif. company is one of three biotech firms InterWest has recently backed, including antiviral creator Eiger BioPharmaceuticals and autoimmune drug maker Lycera.
Previously, Autonomic raised a $5 million first round of capital from Kleiner Perkins Caufield & Byers and the Cleveland Clinic.
Life sciences briefing: Monday, Jan. 14, 2008
TODAY’S HEADLINES:
Autonomic Technologies raises $3M for neurostimulators (PE Hub)
Canopy Financial raises $15M for outsourced healthcare management (release)
Cancer-drug developer AmpliMed draws $5M (PE Hub)
Caprotec Bioanalytics receives €6M for protein-analysis tech (release)
ProtAffin draws additional €1.4M for anti-inflammatory drugs (release)
Toxicology-services firm Bridge Labs takes in $18M (release)
Dental-compound maker NovaMin takes in $2.2M (TechJournal South)
Aushon Bio takes in $4M for microarrays (PE Hub)
Treatment Online receives $750K for Web behavioral healthcare (PDF release)
IPO the Hospitalist aims to raise $60M with… Continue Reading